Ranbaxy, Teva Anti Trust Hit!
  • Prabha Hedge
  • Feb 19 2014

February 19: It is a $300 thousand anti-trust hit for Ranbaxy and Teva. The two drug makers have agreed to settle New York State claims that they colluded to protect each others exclusivity in generic drug sales.